This inventor holds 1 USPTO granted patent. Top assignee: Kong Kook Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Mork Soon Park: Innovator in Sustained Release Microparticles
Introduction
Mork Soon Park is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microparticles. His innovative approach has the potential to enhance therapeutic effects for various medical applications.
Latest Patents
Mork Soon Park holds a patent for a "Sustained release microparticle and method for preparing the same." This patent discloses a method for preparing sustained release microparticles that release a physiologically active substance over extended periods. The process involves a multi-emulsion technique where a drug of interest is dissolved or dispersed in at least two oils, each containing a biodegradable polymer. The primary oil phases are then dispersed in an aqueous phase, leading to the formation of microparticles after the removal of organic solvents. This method allows for the continuous release of drugs, such as leutenizing hormone-releasing hormones, improving their therapeutic effects.
Career Highlights
Mork Soon Park is associated with Kong Kook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that can significantly impact patient care and treatment outcomes.
Collaborations
Mork Soon Park has collaborated with notable colleagues, including Il Ho Lim and Ung Kil Jee. Their combined efforts contribute to the advancement of pharmaceutical technologies and innovations.
Conclusion
Mork Soon Park's contributions to the field of sustained release microparticles exemplify the importance of innovation in pharmaceuticals. His work not only enhances drug delivery systems but also holds promise for improving therapeutic outcomes in various medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile